<DOC>
	<DOCNO>NCT01073904</DOCNO>
	<brief_summary>A single dose , two treatment ( Postinor-2 Opxion ) , two period , two sequence , crossover , randomize , prospective design choose washout 14 day two study period . Treatment group balance number male healthy volunteer randomly assign study drug administration sequence .</brief_summary>
	<brief_title>Cross-over Study Prove Bioequivalence Between Two Oral Formulations Levonorgestrel 1.5 mg</brief_title>
	<detailed_description />
	<mesh_term>Levonorgestrel</mesh_term>
	<mesh_term>Norgestrel</mesh_term>
	<criteria>Healthy male volunteer age 18 55 year old normal vital sign , electrocardiogram ( ECG ) , blood chemistry , liver function profile urinalysis . History illnesses organic abnormality could affect result study . History tobacco alcohol abuse regular use recreational therapeutic drug . Subjects take medication within 14 day elimination period le 7 halflives ( whichever long ) study startup .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>April 2014</verification_date>
</DOC>